Unibest

Pharmaceutical intermediates

Saxagliptin Intermediates

5 pharmaceutical intermediates for Saxagliptin. Indication: Type 2 diabetes mellitus.

Submit a ProjectAll intermediates

About Saxagliptin

Originator
Bristol Myers Squibb
Indication
Type 2 diabetes mellitus
Approved Date
07/31/2009
DS/DP
11/30/2028

Available intermediates

5 intermediates currently listed for Saxagliptin. Request specifications, documentation or a quotation for any item below.

Saxagliptin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate709031-45-8//
Boc-3-Hydroxy-1-adamantyl-D-glycine361442-00-4//
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester361440-67-7//
(S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester178172-26-4//
(1R,3R,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid1148048-39-8//

Other programs under S

SaracatinibSarecycline HydrochlorideSarolanerSeladelparSeltorexantSemaglutideSitafloxacin hydrate Sofosbuvir

Building toward Saxagliptin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →